Oncolytics Biotech Inc.
Oncolytics Biotech Inc. (ONCY) Revenue
Annual & quarterly revenue history · segment & region breakdown
ONCY · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsOncolytics Biotech Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Oncolytics Biotech Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Oncolytics Biotech Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Oncolytics Biotech Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ONCY revenue · 4 questionsONCY's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Oncolytics Biotech Inc. SEC filings · GAAP · Oncolytics Biotech Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026